Calcium Hydroxyapatite

In short: Calcium hydroxyapatite (CaHA), branded Radiesse, is a two-phase filler-biostimulator: immediate CMC gel volume and late-phase (2-3 months) collagen neogenesis. It is long-term (12-18 months), resistant to hyaluronidase reversal with HA and is preferred for special indications (jawline, hands, facial volume).

Description

Calcium hydroxyapatite (CaHA; chemical formula Ca₁₀(PO₄)₆(OH)₂) is the mineral building block of the human skeleton. It naturally constitutes 70% of bone matrix mineralization and the main mineral composition of tooth enamel and dentin. In the context of medical aesthetics, calcium hydroxyapatite injection products (most commonly Radiesse, Merz Aesthetics) process this natural mineral into spherical particles with a diameter of 25-45 μm (microns) and are presented in a carrier matrix. The Radiesse product was specifically prepared in a composition of 30% CaHA microspheres + 70% carboxymethyl cellulose (CMC) hydrogel.

The uniqueness of CaHA from the facial aesthetician's perspective two-phase mechanism of actionlies in: (1) First phase — Instant Fill (0-6 months): CMC gel pinch provides facial contouring and lifting effect by providing immediate volume after injection. Patients see “instant results.” (2) Second phase — Biostimulation (after 2-3 months): Macrophages and fibroblasts gather around CaHA particles and slowly absorb the particles, while simultaneously stimulating neo-collagen synthesis. This "collagen neogenesis" process begins 2-3 months after injection and continues after the product is completely absorbed (3-6 months). The result: no permanent collagen contribution remains, a rigid and inelastic resorbed "skeleton", but instead the patient's own collagen matrix develops.

In clinical practice, CaHA is particularly jawline contouring, mid-face volumization, hand rejuvenation and hyperdiluted protocols (1:1 or 1:2 saline dilution) is preferred for skin quality improvement. Because Merz Aesthetics does not recognize CaHA's potential for improving skin quality, Radiesse has not gone as far as marketing it as a "skin booster," although academic studies document this potential.

Chemical Structure and Minerology

Crystal Purity on a micron scale: The CaHA particle is created from synthetically produced calcium phosphate crystals. It is isomorphic (same shape) to natural bone mineral but has a high content of synthetic CaHA, pure and crystalline. Particle size 25-45 μm% — this range is critical: very small particles (<10 μm) are absorbed too quickly by the body (short-acting) and fibroblast stimulation is reduced; very large particles (>100 μm) can cause local inflammation and increase the risk of granulomas.

Biocompatibility and Osseointegration: Because CaHA is chemically identical to native bone mineral, the body recognizes it as a "native" material. Slow resorption by macrophages initially initiates a “scavenging phase”—macrophages phagocytose the particles but release IL-6 (interleukin-6) and other cytokines during this process. The release of this cytokine stimulates fibroblasts and osteoblasts, triggering type I collagen and proteoglycan synthesis. Result: "foreign body" reaction is minimal, but biostimulative response is maximal.

Radiopacity and Imaging: Because of their calcium content, CaHA particles appear radiopaque (white in color) on X-ray and CT scans. This can be especially important during facial radiology and surgical planning. Some patients (e.g. an easy CT around the eye) may see a white spot or lacing at the injection site during the scan. Intensive CT scanning (e.g., for bone detail) can alert the clinician to the presence of CaHA.

Product Features: Radiesse and Radiesse(+)

Radiesse Formulation: Radiesse, manufactured by Merz Aesthetics, is marketed in a 1.5 mL injection syringe. Contents of the syringe: 0.4 mL CaHA particles (25-45 μm) + 1.1 mL CMC (carboxymethyl cellulose) gel carrier. CMC is a low viscosity, water-based polymer and is absorbed by the body within 4-6 weeks after injection. CaHA particles are kept dispersed as a "float" in this CMC.

Radiopacitev Marker — Barium Sulphate: Radiesse product contains 6% barium sulfate for a radiopaque appearance of urine. This shows the location of the injection on X-ray and CT scan and helps in clinical endodontic or surgical planning.

Radiesse(+) — Lidocaine Version: In 2019, Merz introduced a version with lidocaine called Radiesse(+). This formulation contains 0.3% lidocaine (topical anesthetic), reducing pain during injection. Patients report a “less painful” injection experience with Radiesse(+). Efficacy and biostimulative capacity are the same as the original Radiesse.

Viscosity Profile: Radiesse is not "moldable" like the HA filler — it has a more "pushed" texture. The physician can inject Radiesse in a line (linear threading) or fan pattern during injection. The viscosity is initially suitable for injection (3,000-4,000 cP — centipoise), and the gel hardens immediately after injection. This secures the injection pattern—the clinician should then keep back-and-forth massage to a minimum.

How to Apply

CaHA (Radiesse) injection requires more careful technique than HA filler injection. A typical session lasts 20-30 minutes:

1. Consultation and Goal Setting: The physician evaluates the patient's facial structure, asymmetry, volume loss and the desired result. Because CaHA is more permanent (12-18 months) and is longer than HA (12-14 months), the physician and patient determine the contour targets precisely. Injection areas are marked with a soft pencil — typical areas: jawline, zygomatic bone (cheekbone), nasalabial fold depth, dorsal hand (back of the hand).
2. Preparation — Skin Cleansing and Anesthesia: The application area is cleaned with antiseptic solution (70% ethanol or chlorhexidine). Cryotherapy (cold application) or topical anesthetic cream (4% lidocaine + prilocaine — EMLA) is optional. Intravenous (IV) sedative optional (for deep volume injections). If Radiesse(+) is used, topical anesthesia may remain minimal.
3. Product Preparation — Hyperdilatation Protocols: A hyperdiluted form can be prepared by diluting Radiesse. Standard Radiesse is 1:0 (pure) and gives full filler volume. Hyperdilated forms:
   • 1:1 dilution (50% Radiesse + 50% saline): For skin quality and texture – used in microdroplet technique (dermal plane, 2-3 mm depth) injection. Lighter volume, more collagen stimulation (particles dispersed over a wider area)
   • 1:2 dilution (33% Radiesse + 67% saline): Maximal skin quality boost — similar microdroplet; surface area exposed to finer, more particles
   • Standard 1:0: Jawline, volume injection, hand rejuvenation — in deep subdermal or supraperiosteal (above bone) plane
   The physician gently mixes Radiesse + sterile saline in a sterile syringe—avoiding hypotonicity (use saline, not distilled water).
4. Technique — Injection Depth and Method: Injection depth depends on the target area:
   • Jawline contouring (standard CaHA): Supraperiosteal — just above the bone surface of the mandible (2-3 mm) or subperiosteal (below the mandible). Needle caliber: 27 G or 25 G, 38-50 mm length (cannula optional, cannulated injection more preferable)
   • Midface volumization (cheekbone, temporal): Subdermal (deep dermis) or supramuscular (above the muscle). Depth 3-5mm
   • Skin quality hyperdilute (1:1 or 1:2): Dermal — Serial injections at a depth of 2-3 mm (microdroplet technique). Inject 0.1-0.2 mL into each area (40-50 inject points per face)
   • Hand rejuvenation: On the dorsal hand; subdermal + deep dermal, away from extensor tendons
   Dosage: For jawline and midface, typical dose is 1-2 mL per session. Skin quality (hyperdilute) application 4-8 mL (whole face), multi-quantity injection. Hand rejuvenation, 0.6-1.2 mL in each hand.
5. Post-injection — Massage Minimization: Immediately after Radiesse injection, the clinician MINIMALLY massages. Unlike HA fillers, aggressive "back-and-forth massage" is not done — Radiesse CMC gel is about to harden and massage can move the product and distort the contour. Rather, the patient is instructed to "do no massage, no strenuous exercise, no extreme heat exposure (sona, steam) for the first 48 hours."

Indications

FDA Approved Indications:

• Contouring the face (Facial folds): Midface volume loss, nasalabial fold depth
• Marionette lines: Expressionless lines descending from the corner of the mouth to the chin
• Hand rejuvenation: Dorsal hand (upper hand) aging, ossification, lines, loss of skin quality — Radiesse 0.6-1.2 mL injection into each hand, FDA approved

Off-Label Uses (Medium evidence):

• Jawline contouring: Volumization of mismatched jaw contour, narrow or weak jawline
• Cheekbone projection (zygomatic bulge): Cut-away, defined dead-end look of the face
• Correction of temporal hallowing (temporal depression)
• Neck and décolletage rejuvenation (crepey skin): Hyperdilute (1:1 or 1:2) microdroplet technique
• Skin quality improvement (Skin quality boost): Hyperdilute Radiesse improves turgidity (skin tension) and luminosity (skin brightness) by increasing dermal volume. Histology shows increased synthesis of type I collagen
• Attenuation of Scars: To fill atrophic (collapsed) scars, CaHA may be more useful than HA due to its long-term biostimulation
• Combo treatments (Radiofrequency + Radiesse): Combination of skin tension and Radiesse volumization with RF devices gives synergistic effect

Contraindications and Warnings

• Lip injection — CONTRAINDICATED: Lips are not suitable for Radiesse as they have a high range of motion. CaHA particles show healing incompatible with lip tissue, with a high risk of nodular granuloma and palpable initiation. HA or PLLA is preferred for lips
• Periocular (around the eyes) injection — CONTRAINDICATED: There is a risk of very thin skin, microvascular vasculature and tyndall (whitish) under the eyes. HA is preferred; In rare cases (periosteal injection too deep) CaHA can be used, but there is a radical contraindication
• Active infection and herpes simplex: If there is an active HSV lesion at the application site, the injection is delayed (2-4 weeks) — to avoid inflammation
• Excessive anticoagulation: INR >3 or active dual antithrombotic therapy—risk of bleeding; Coagulometry is done after correction
• Immunosuppression and healing impairment: Controlled diabetes, chronic systemic steroid use—slow recovery, increased risk of granulomas
• Pregnancy: Contraindicated—insufficient safety data
• Allergy: Direct allergy to CaHA is rare; However, hypothetical allergy to CMC or barium sulfate may be very rare.

Effect Duration and Timing

CaHA (Radiesse) effect duration table:

Radiesse (CaHA) — Effect Duration and Phase Table

Stage	Duration	Clinician Observation	Patient Report
Injection and immediately after	0-2 hours	Maximal swelling, contour clear; CMC gel provides 100% volume	"My face is so swollen, it looks excessive"
CMC gel absorption begins	6-24 hours	Swelling is reduced by 30-40%	Noticeable reduction in swelling
CMC gel absorption continues	1-6 weeks	The volume gradually decreases, but CaHA particles remain	"My face has 'deflated' a bit, but there are still results"
Collagen neogenesis begins	2-3 weeks	By palpation, the clinician feels the tissue "stay firm"	The tissue feels harder
CMC gel absorption ok, collagen biostimulation peak	4-8 weeks	Volume is stable; CaHA particles are "surrounded" by the macrophage, collagen deposition is maximal.	"My face looks fuller and firmer; the skin is more elastic"
CaHA resorption continues, collagen retention	2-6 months	Gradually, CaHA particles disappear, and the place they leave is filled by the collagen matrix.	Volume gradually returns, but skin quality remains improved
Impact plateau (equilibrium)	6-12 months	CaHA is almost completely resorbed; permanent collagen deposition remaining	"I still feel results, but not as much as after the injection"
The effect begins to fade	12-15 months	Collagen deposition slowly begins to "recover"	Volume begins to return slightly
Effect remains minimal or has returned	15-18 months	After a year or two, most patients find that the injection effect has completely disappeared.	"Result lost, I need a refresh"

Detailed Phase Analysis:

Hours 0-6 — First Phase Hyper-Volume (CMC Gel "Peak"): Immediately following injection, the CMC gel is in a state of maximal hydration and swell. Patients may appear “too swollen” — this often results in an overfilled appearance beyond the injection target. The clinician instructs the patient, "swelling is normal for the first 24-48 hours, do not worry." Within 2-6 hours, swelling decreases by 20-30% because CMC immediately begins to lose its hydration (absorption by the body begins).

Days 1-7 — As the CMC Gel Absorption Phase Continues, Biostimulation Begins: This period is the period with the most "deflated" appearance. Patients may say "my face is so deflated, I wasted money" in the first week — but this is normal. CMC gel is quickly absorbed (70-80% within 5-7 days), whereas CaHA particles remain. Macrophages have already begun to approach CaHA, inflammation (mild) has begun. Within 3-4 days, the tissue may begin to harden (increase in firmness) — this is the sign of biostimulation.

Week 2-4 — Collagen Neogenesis Peak, Volume Becomes Stable: At this stage, the CMC gel was almost completely absorbed (90%). The CaHA particles now remained "naked", and fibroblasts clustered around it. Collagen type I synthesis is at peak level. The clinician feels the tissue "harder, more resistive" on palpation. Patients report "my face feels firm" or "skin is firmer and more elastic." The volume is now stable and much less dramatic than the initial "overfilled" look — but the result is still noticeable.

Months 1-6 — Long Phase Collagen Biostimulation and CaHA Resorption Continue: You can consider these 5 months as a "golden window" — the result is stable, noticeable, and the skin quality is still high. CaHA particles are slowly absorbed by macrophages. Histology studies show that type I collagen deposition continues during this period. Skin quality (texture, turgor, luminosity) remains improved because collagen is supported by the new pressure. Patients report "skin looks healthier, not just plumper."

Months 6-12 — Collagen Permanence, CaHA Almost Completely Gone: Within 6-8 months, histology finds almost all CaHA particles resorbed. However, in their place, he left a permanent "collagen matrix" (collagen skeleton). This collagen is new and organic, consisting of the patient's own fibrils. The volume at this point is still 30-50% increased compared to the pre-injection state, but the post-injection peak volume has now shifted. Patients report "the result is still evident, but subsided." Skin quality improvement (visibly healthier skin, improved elasticity) can still be observed during this period.

Month 12-18 — Collagen Depot "Normalization", Effect Begins to Lose: After a year, the collagen created by the body slowly returns to its "normal renewal cycle". Some collagen remains (because new connective tissue is permanent), but the effect gradually weakens. During this period, patients feel that 20-30% of the injection effect remains. The skin quality improvement is still partially there, but the need for volume restoration may begin. Reinjection noise may begin at this point.

Average Effect Duration: Most sources report around 12-18% loss for months — but this does not mean a "100% potency" loss. More accurate: "pronounced volumetric effect 12-18%, after which gradual return is completed in 18-24 months."

Risks and Side Effects

CaHA (Radiesse) injection is a generally safe procedure and has as low-risk a profile as HA filler. But there are specific risks:

Common and Mild

• Swelling (Edema): For the first 24-72 hours after the injection, mild to moderate swelling at the injection site is normal. It is most often managed with antihistamines and cold compresses. It speeds up cold mask (cryo-mask) application.
• Ecchymosis and Hematoma: Blue-purplish color around the injection site, remaining for 3-7 days. Arnica, bromelain or silica gel can speed healing.
• Redness (Erythema): Slight redness at the injection site resolves within 24-48 hours.
• Temporary pain/burning: During injection and within 24 hours — Pain is minimal in the Radiesse(+) lidocaine form.

Rare but Clinically Important

• Palpable Nodular Granuloma (Papule/Nodule): CaHA particles can cause local inflammation, especially in case of very superficial injection (<2 mm) or contamination (non-sterile technique). Patients may feel a "hard bulge under the chin." Treatment: intralesional steroid (triamcinolone 40 mg/mL, 0.1-0.2 mL), or in rare cases surgical removal.
• Tyndall Effect (Whitish Appearance): In very superficial injection (1-2 mm), the area may appear whitish-blue due to light scattering. Due to the particulate structure of CaHA, it is more exposed to this effect than HA. Treatment: healing (if the gel component is absorbed) or hyaluronidase DOES NOT help (the structure of CaHA is hyaluronidase resistent), surgical removal may be required instead.
• Skin Tethering: If CaHA particles are injected too compactly (in clusters), they may cause shrinkage on the skin. Treatment: massage (carefully for the next 2-3 weeks) or intralesional steroids.
• Vascular Occlusion: Rare but serious — if the injection accidentally enters an artery. CaHA particles can form embolism. Acute symptom: sudden pain after injection, skin pallor (whitening), existing vascular pain. Treatment: urgent consultation with a physician, vasodilator (nitroglycerin), intervention may be required. In Radiesse, the barium sulfate "radiopaque marker" helps to immediately identify the vascular framework.
• Infection (Non-Sterile Technique): rare; ecchymosis, swelling and pain worsen after week-1, fever symptom. Treatment: antibiotics, sometimes drainage or removal of urine.

Very Rare/Serious

• Anaphylaxis (unreported, <1 case per million)
• Nerve damage (rare, very low risk by experienced physician)
• Systemic CaHA diffusion (this risk is minimal due to its resorption by the body; CaHA is either resorbed within the body or remains local in the tissues)

Reversibility and Complication Management

No, CaHA IS HYALURONIDAZE DISSOLVED — This is the Critical Difference: HA filler (Restylane, Juvéderm) can be dissolved quickly with hyaluronidase injection. However Due to its CaHA mineral structure, it is RESISTENT to hyaluronidase.is. Hyaluronidase cuts the hyaluronic acid polymer in HA; however, it cannot resolve the calcium phosphate crystal structure in CaHA.

Solution Options (In Case of CaHA Complication):

• Wait-and-See: Most CaHA complications (mild nodule, mild tyndall) resolve over time—during the 2-6 month wait, vascularization and resorption are completed and the tissue "normalizes"
• Intralesional Steroid (Triamcinolone): For nodular granuloma, inject 40 mg/mL triamcinolone acetonide, 0.1-0.2 mL directly into the lesion—suppresses inflammation, shrinks the nodule. Repeat after 2-4 weeks is optional
• Intralesional Sodium Thiosulfate (Sodium Thiosulfate): Some academic studies have suggested that sodium thiosulfate (STS) may have a “dissolutive” effect against CaHA. The mechanism is not clear; however, calcium comparison is possible through biochemical redox reactions. Usage: Inject 0.5-1 mL of 24% STS (strong biochemistry) directly into the lesion. The result is variable; This is not yet standard treatment, but an experimental option in severe cases.
• Surgical Removal: If there is a persistent, severe lesion, surgical excision (surgical removal of the mass) is a defined treatment—but invasive. It is typically used in case of anya onset (micro-injection severe nodule).
• Laser Treatment (Experimental): Some dermatologists have tried Q-switched laser (1064 nm) applications on CaHA particles, the mechanism of which is fragmentation (agitation). The evidence is limited.

Comparison: CaHA vs. Hyaluronic Acid vs. PLLA

Filler Comparison: CaHA (Radiesse) vs. HA (Restylane/Juvéderm) vs. PLLA (Sculptra)

Parameter	CaHA (Radiesse)	Hyaluronic Acid (HA)	Poly-L-Lactic Acid (PLLA)
Works Mechanism	CMC gel instant + CaHA biostimulation	Osmotic retention (attracts water)	Pure biostimulation (collagen stimulation)
First Phase (Instant Volume)	Yes — CMC gel	Yes — HA + water	No — starts week 3-4
Biostimulation (Collagen)	Yes — strong, 2-3 months	Mild (stimulates endogenous hyaluronic acid synthesis)	Yes — very strong, 2-6 month peak
Effect Duration	12-18 months	12-14 months (branded HAs 18-24 months)	18-24+ months (longer with cumulative sessions)
reversibility	Partial—standby or steroids, NOT hyaluronidase	FULLY reversible — hyaluronidase injection	No — just standby/steroids
Hyperdilute Skin Quality	Yes — 1:1 or 1:2 microdroplet	Yes — microdroplet (NCTF, Sunekos)	Yes — hyperdilute Sculptra microdroplet
Geology (Inectability)	Granular — "pushed", linear or fan	Viscoelastic — moldable, malleable	Microparticle — diluted, microdroplet
For Lips	CONTRAINDICATE — risk of granuloma/nodule	Preference — moldable, safe	Contraindicated—palpable nodules
For Under Eye	Risky — tyndall, contraindicated	Preference—thin detachable forms	Risky — nodules
Jawline/Volume	Selection—midface, cheekbone, jawline; permanent	Selection—most filler applications	Preference — very deep, aggressive volume
Price (TL, 1 ml)	₺400-600	₺300-500	₺500-800
Reinjection Frequency	Every 12-18 months	Every 12-14 months	Every 18-24 months
Cumulative Impact	Mild with long-term use — collagen is "resorbed"	Minimal—collagen minimal after repeated injection	Very Powerful — serial injections create permanent-like collagen

Clinician Perspective: CaHA offers the “middle ground” between HA and PLLA — immediate results + long biostimulation. It is preferred in jawline and midface volumization. HA is safe for lips and thin areas. PLLA is preferred for those who want maximal permanent biostimulation.

Alternatives and Combination Therapies

Alternative Treatments:

• Hyaluronic Acid (HA) Filler: More moldable, reversible; More preferable for jawline and lips
• PLLA (Sculptra): More permanent biostimulation; For severe volume loss
• PDO Thread Lift: Mechanical lift; Effective for 1-3 years
• Radiofrequency (RF) Microneedling: Skin tension and collagen stimulation; separate transaction
• Laser Resurfacing: Superficial skin quality; Complementary with CaHA

Combination Therapies (Synergy):

• CaHA + HA (Layered Approach): CaHA (deep) for jawline and cheekbone, then HA (dermal plane) for sensitive skin quality
• CaHA + PDO Thread Lift: CaHA volume + PDO mechanical lift = maximal jawline contour
• Hyperdilute CaHA + RF Microneedling: CaHA skin quality boost + RF tension = skin tightening + quality combo
• CaHA + Botox (Maceteric/Facial): CaHA jawline volume + masseter botox V-line thinning = maximal jaw shaping
• CaHA + Microneedling (Roller/Stamp): CaHA deep volume + mechanical collagen stimulation = dual biostimulation

Hyperdilute CaHA and Skin Quality Applications

In the last 5-6 years, "hyperdilute Radiesse" (1:1 or 1:2 saline dilution) protocols have attracted attention in academic publications, opening a new path for skin quality improvement. Concept: If CaHA particles are very finely dispersed (microdroplet technique, 0.1-0.2 mL every 2-3 mm), it stimulates biostimulation over a larger area and skin texture, luminosity and turgidity (tension) are improved.

Protocol: The entire 1.5 mL of standard Radiesse is mixed with sterile saline at a 1:1 ratio (3 mL total, 33% CaHA concentration). The injection site is determined on the entire face (T-zone, cheeks, chin) and intradermal injection is made at 40-50 "microdroplet" points — depth 2-3 mm. The clinician may prefer a "wet technique" with saline—better control and diffusion during injection. The patient may see many small "papules" (small bumps) in the first 48 hours — this is normal, subsiding within 1 week.

Result:** After 4-8 weeks, the skin looks "surprisingly healthy and elastic". Texture improves, fine lines lighten, skin brightness increases. Histology: increased dermal collagen density. Compared to HA microbooster protocols (Sunekos, NCTF), hyperdilute CaHA may offer greater collagen stimulation—but the risks of hematoma and ecchymosis are slightly increased (multiple injection points).

Related Terms

• Filler
• Hyaluronic Acid (HA)
• Poly-L-Lactic Acid (PLLA / Sculptra)
• Biostimulator Filler
• Radiesse Product
• Jawline Contouring
• Collagen Neogenesis
• Vascular Occlusion

Frequently Asked Questions

1. Can CaHA be dissolved by hyaluronidase?
   No — that's the critical difference. CaHA mineral structure is resistant to hyaluronidase. Hyaluronidase only cuts HA (hyaluronic acid). Complications of CaHA are managed by waiting, steroids, or surgical removal.
2. Can CaHA be used on lips?
   It is contraindicated. Since the lips have a high range of motion, CaHA particles create the risk of nodular granuloma and palpable initiation. HA or PLLA is preferred.
3. Is the CaHA effect duration really 12-18 months?
   Average yes. But it varies among individuals — 15-20% patients report loss of effect at 10-12 months; 10-15% stays for 18-24 months or even longer. Metabolic rate affects age, skin health, and endogenous collagen synthesis.
4. How many days will there be pain after CaHA injection?
   Minimal pain. Mild discomfort at the injection site for the first 24 hours. In the form with Radiesse(+) lidocaine, the pain is almost zero. Analgesic is rarely necessary.
5. Does Hyperdilute CaHA improve skin quality?
   Yes—studies show microdroplet injection at a 1:1 or 1:2 dilution provides dermal collagen increase and skin texture improvement. Visible results after 4-8 weeks.
6. What is the risk of CaHA nodules?
   Rare but possible — 2-3% in very superficial injection (~1 mm). Deep technique (3-5 mm) minimizes the risk. Treatment: intralesional steroids or waiting.
7. Is CaHA safe for hands?
   Yes — FDA-approved indication. Dorsal hand injection, 0.6-1.2 mL of CaHA in each hand, improves skin texture, signs of aging, and ossification.
8. Is the CaHA + botox combination safe?
   Yes — very safe. Example: CaHA jawline (volume) + masseter botox (V-line) combination creates synergy. It can be done in the same session or 1-2 weeks apart.
9. Can CaHA be used during pregnancy?
   Contraindicated—insufficient safety data. All injection treatments are postponed during pregnancy and breastfeeding.
10. Does CaHA show the Tyndall effect?
    Yes — especially for very superficial injection (1-2 mm). Due to its particle structure, the risk of Tyndall is higher than HA. It minimizes the risk of deep injection (>2 mm).

Dr. Hamza Gemici Comment

"Calcium hydroxyapatite (Radiesse) is a contemporary filler option that provides long-term biostimulation and permanent collagen deposition. Jawline is more effective than HA in contouring and mid-face volumization because it stays for 12-18 months and stimulates collagen. However, Radiesse is dangerous on the lips and under the eyes — HA should be preferred. Hyperdilute protocols are exciting for skin quality improvement, but the microdroplet technique requires a hemostat tendency. In my clinical practice Radiesse is very successful in jawline sharpening and aging hands in male patients — the results are natural and long-lasting.”

— Op. Dr. Hamza Gemici

Resources and References

This content has been prepared based on FDA-approved product monographs, international dermatology literature and clinical studies.

Last update: 21 April 2026 · Medical editor: Op. Dr. Hamza Gemici